“…The injection interval was chosen for two reasons: 1) to limit the exposure of the muscle to the protein in order to minimize potential direct effects on the muscle and 2) the hIGF-1-TTC fusion protein is detectable in the spinal cord for 21 days post-injection (Payne, et al, 2006). TTC was chosen as the carrier for hIGF-1 based on its rapid uptake from muscle and subsequent retrograde axonal delivery to spinal cord motor neurons (Coen, et al, 1997,Fishman and Carrigan, 1987,Fishman and Savitt, 1989,Miana-Mena, et al, 2002. Indeed, in a previous report, our laboratory has shown that the hIGF-1-TTC protein undergoes quick retrograde axonal transport to the spinal cord following intramuscular injection (Payne, et al, 2006).…”